| calcium channel, voltage-dependent, beta 4 subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
NIMODIPINE |
Calcium Channel Type L, Benzothiazepine |
83% |
.002093uM |
.00186uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| adrenergic receptor, alpha 2a |
FLUPHENAZINE |
Imidazoline I2, Central |
83% |
4.369uM |
2.912uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
FLUPHENAZINE |
Imidazoline I2, Central |
83% |
4.369uM |
2.912uM |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
TOLMETIN |
Aldose Reductase |
83% |
2.153uM |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
TOLMETIN |
Aldose Reductase |
83% |
2.153uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
TOLMETIN |
Aldose Reductase |
83% |
2.153uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
TOLMETIN |
Aldose Reductase |
83% |
2.153uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
DOMPERIDONE |
Adrenergic alpha2B |
83% |
2.125uM |
.97uM |
View
|
| opioid receptor, sigma 1 |
LABETALOL |
Sigma1 |
83% |
1.815uM |
.763uM |
View
|
| histamine receptor H 2 |
GENTIAN VIOLET |
Histamine H2 |
83% |
1.155uM |
1.136uM |
View
|
| mu-opioid receptor MOR |
GENTIAN VIOLET |
Opiate mu |
83% |
2.145uM |
.871uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
GENTIAN VIOLET |
Calcium Channel Type L, Dihydropyridine |
83% |
2.133uM |
1.371uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CITALOPRAM |
Calcium Channel Type L, Benzothiazepine |
83% |
1.786uM |
1.588uM |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
CISPLATIN |
ATPase, Na+/K+ |
83% |
9.427uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
CISPLATIN |
ATPase, Na+/K+ |
83% |
9.427uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
CISPLATIN |
ATPase, Na+/K+ |
83% |
9.427uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
CISPLATIN |
ATPase, Na+/K+ |
83% |
9.427uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
CISPLATIN |
ATPase, Na+/K+ |
83% |
9.427uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
CISPLATIN |
ATPase, Na+/K+ |
83% |
9.427uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
CISPLATIN |
ATPase, Na+/K+ |
83% |
9.427uM |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
CISPLATIN |
ATPase, Na+/K+ |
83% |
9.427uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
PROCHLORPERAZINE |
Serotonin 5-HT4 |
83% |
1.164uM |
.194uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
PROCHLORPERAZINE |
Serotonin 5-HT4 |
83% |
1.164uM |
.194uM |
View
|
| progesterone receptor |
ETHYNODIOL DIACETATE |
Progesterone |
83% |
.16uM |
.021uM |
View
|
| progesterone receptor |
ETHYNODIOL DIACETATE |
Progesterone |
83% |
.16uM |
.021uM |
View
|
| mitogen-activated protein kinase 1 |
TROGLITAZONE |
Protein Serine/Threonine Kinase, ERK2 |
83% |
1.238uM |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
TROGLITAZONE |
Protein Serine/Threonine Kinase, ERK2 |
83% |
1.238uM |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
MICONAZOLE |
Acetylcholinesterase |
83% |
18.659uM |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
MICONAZOLE |
Acetylcholinesterase |
83% |
18.659uM |
NoneNone |
View
|
| acetylcholinesterase |
MICONAZOLE |
Acetylcholinesterase |
83% |
18.659uM |
NoneNone |
View
|
| thromboxane A synthase 1 |
MICONAZOLE |
Thromboxane Synthetase |
83% |
.263uM |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
MICONAZOLE |
Thromboxane Synthetase |
83% |
.263uM |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
METYRAPONE |
CYP450-3A4 Inhibition |
83% |
.8uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
ERGOCORNINE |
Imidazoline I2, Central |
83% |
.004487uM |
.002991uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
ERGOCORNINE |
Imidazoline I2, Central |
83% |
.004487uM |
.002991uM |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
DANAZOL |
Glucocorticoid |
83% |
4.314uM |
1.961uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid A receptor, pi |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid A receptor, theta |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid A receptor, delta |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
DIETHYLSTILBESTROL |
GABAA, Chloride Channel, TBOB |
83% |
15.09uM |
13.529uM |
View
|
| adrenergic receptor, beta 1 |
METOPROLOL |
Adrenergic beta1 |
83% |
.176uM |
.102uM |
View
|
| adrenergic, beta-1-, receptor |
METOPROLOL |
Adrenergic beta1 |
83% |
.176uM |
.102uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
DIMENHYDRINATE |
Adrenergic alpha1D |
83% |
2.894uM |
1.423uM |
View
|
| epidermal growth factor receptor |
BACITRACIN |
Protein Tyrosine Kinase, EGF Receptor |
83% |
5.377uM |
NoneNone |
View
|
| progesterone receptor |
TESTOSTERONE |
Progesterone |
83% |
1.935uM |
.252uM |
View
|
| progesterone receptor |
TESTOSTERONE |
Progesterone |
83% |
1.935uM |
.252uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
BETA-ESTRADIOL 3-BENZOATE |
Serotonin Transporter |
83% |
3.672uM |
1.951uM |
View
|
| mitogen activated protein kinase 3 |
TANNIC ACID |
Protein Serine/Threonine Kinase, ERK1 |
83% |
4.052uM |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
TANNIC ACID |
Protein Serine/Threonine Kinase, ERK1 |
83% |
4.052uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
EPINEPHRINE |
Adrenergic alpha2C |
83% |
2.449uM |
.356uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
EPINEPHRINE |
Adrenergic alpha2C |
83% |
2.449uM |
.356uM |
View
|
| Protein-tyrosine kinase, Fyn |
TANNIC ACID |
Protein Tyrosine Kinase, Fyn |
83% |
.022uM |
NoneNone |
View
|
| opioid receptor, kappa 1 |
AMIODARONE |
Opiate kappa |
83% |
16.68uM |
6.672uM |
View
|
| melanocortin 3 receptor |
AMIODARONE |
Melanocortin MC3 |
83% |
12.372uM |
10.797uM |
View
|
| melanocortin 3 receptor |
AMIODARONE |
Melanocortin MC3 |
83% |
12.372uM |
10.797uM |
View
|
| opioid receptor, kappa 1 |
CHLORPROMAZINE |
Opiate kappa |
83% |
11.082uM |
4.433uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
TROPICAMIDE |
CYP450-2C19 Inhibition |
83% |
1uM |
NoneNone |
View
|
| opioid receptor, delta 1 |
TAMOXIFEN |
Opiate delta |
83% |
13.339uM |
4.702uM |
View
|
| phosphodiesterase 3B |
CILOSTAMIDE |
Phosphodiesterase PDE3 |
83% |
.055uM |
NoneNone |
View
|
| phosphodiesterase 3A |
CILOSTAMIDE |
Phosphodiesterase PDE3 |
83% |
.055uM |
NoneNone |
View
|
| opioid receptor, sigma 1 |
TETRACAINE |
Sigma1 |
83% |
1.673uM |
.703uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.687uM |
1.499uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
FLUNARIZINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.12uM |
.995uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
FLUNARIZINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.12uM |
.995uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
FLUNARIZINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.12uM |
.995uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
FLUNARIZINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.12uM |
.995uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
FLUNARIZINE |
Calcium Channel Type L, Benzothiazepine |
83% |
1.12uM |
.995uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
DROPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.165uM |
4.049uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
DROPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.165uM |
4.049uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DROPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.165uM |
4.049uM |
View
|
| adrenergic receptor, beta 1 |
ESMOLOL |
Adrenergic beta1 |
81% |
.197uM |
.1137uM |
View
|
| adrenergic, beta-1-, receptor |
ESMOLOL |
Adrenergic beta1 |
81% |
.197uM |
.1137uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Serotonin 5-HT2B |
81% |
1.86uM |
1.183uM |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
CYP450-2C9 Inhibition |
81% |
2uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
MITOTANE |
Adrenergic alpha2A |
81% |
7.347uM |
2.755uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
L-744832 |
Calcium Channel Type L, Benzothiazepine |
81% |
3.568uM |
3.172uM |
View
|